OPTIMIST-A Trial Investigators. Minimally invasive surfactant therapy vs sham treatment and death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome-reply. (vol 327, pg 1614, 2022)

被引：0
|
作者：
Dargaville, P. A.
Carlin, J. B.
Davis, P. G.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 11期
关键词：
D O I：
10.1001/jama.2022.8021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2151 / 2151
页数：1
相关论文
共 6 条
  • [1] Minimally invasive surfactant therapy vs sham treatment and death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome-reply (vol 327, pg 1614, 2022)
    Dargaville, P. A.
    Carlin, J. B.
    Davis, P. G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (21): : 2151 - 2151
  • [2] Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome The OPTIMIST-A Randomized Clinical Trial
    Dargaville, Peter A.
    Kamlin, C. Omar F.
    Orsini, Francesca
    Wang, Xiaofang
    De Paoli, Antonio G.
    Kutman, H. Gozde Kanmaz
    Cetinkaya, Merih
    Kornhauser-Cerar, Lilijana
    Derrick, Matthew
    Ozkan, Hilal
    Hulzebos, Christian, V
    Schmolzer, Georg M.
    Aiyappan, Ajit
    Lemyre, Brigitte
    Kuo, Sheree
    Rajadurai, Victor S.
    O'Shea, Joyce
    Biniwale, Manoj
    Ramanathan, Rangasamy
    Kushnir, Alla
    Bader, David
    Thomas, Mark R.
    Chakraborty, Mallinath
    Buksh, Mariam J.
    Bhatia, Risha
    Sullivan, Carol L.
    Shinwell, Eric S.
    Dyson, Amanda
    Barker, David P.
    Kugelman, Amir
    Donovan, Tim J.
    Tauscher, Markus K.
    Murthy, Vadivelam
    Ali, Sanoj K. M.
    Yossuck, Pete
    Clark, Howard W.
    Soll, Roger F.
    Carlin, John B.
    Davis, Peter G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2478 - 2487
  • [3] Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome Reply
    Dargaville, Peter A.
    Carlin, John B.
    Davis, Peter G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1614 - 1615
  • [4] Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm InfantsWith Respiratory Distress Syndrome
    Zhou, Pengxiang
    Han, Tongyan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1613 - 1614
  • [5] MINIMALLY INVASIVE SURFACTANT TREATMENT VERSUS STANDARD THERAPY IN PRETERM INFANTS AT BIRTH (OPTIMIST-A TRIAL): AN ANALYSIS OF INITIAL HOSPITALISATIONCOSTS AND RESOURCE CONSUMPTION
    Cox, I
    de Graaff, B.
    Otahal, P.
    Kamlin, O.
    Orsini, F.
    De Paoli, A.
    Clark, H.
    Soll, R.
    Carlin, J.
    Davis, P.
    Dargaville, P.
    Palmer, A. J.
    VALUE IN HEALTH, 2023, 26 (06) : S69 - S69
  • [6] Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
    Sabzehei, Mohammad Kazem
    Basiri, Behnaz
    Shokouhi, Maryam
    Ghahremani, Sajad
    Moradi, Ali
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2022, 65 (04) : 188 - 193
1